A detailed history of Sg Americas Securities, LLC transactions in Argenx Se stock. As of the latest transaction made, Sg Americas Securities, LLC holds 337 shares of ARGX stock, worth $211,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares
337
Previous 2,999 88.76%
Holding current value
$211,743
Previous $1.29 Million 85.81%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$434.22 - $551.9 $1.16 Million - $1.47 Million
-2,662 Reduced 88.76%
337 $183,000
Q2 2024

Jul 12, 2024

BUY
$356.01 - $451.55 $100,750 - $127,788
283 Added 10.42%
2,999 $1.29 Million
Q1 2024

May 06, 2024

SELL
$356.95 - $413.29 $2.29 Million - $2.65 Million
-6,402 Reduced 70.21%
2,716 $1.07 Million
Q4 2023

Jan 12, 2024

SELL
$338.91 - $506.01 $1.33 Million - $1.99 Million
-3,933 Reduced 30.14%
9,118 $3.47 Million
Q3 2023

Oct 13, 2023

SELL
$369.35 - $548.43 $2.24 Million - $3.33 Million
-6,065 Reduced 31.73%
13,051 $6.42 Million
Q2 2023

Jul 10, 2023

BUY
$360.14 - $422.58 $919,437 - $1.08 Million
2,553 Added 15.41%
19,116 $7.45 Million
Q1 2023

Apr 28, 2023

SELL
$334.23 - $403.65 $651,080 - $786,310
-1,948 Reduced 10.52%
16,563 $6.17 Million
Q4 2022

Feb 02, 2023

BUY
$342.17 - $402.31 $3.57 Million - $4.2 Million
10,440 Added 129.35%
18,511 $7.01 Million
Q3 2022

Oct 31, 2022

SELL
$343.2 - $395.75 $5.12 Million - $5.9 Million
-14,908 Reduced 64.88%
8,071 $2.85 Million
Q2 2022

Jul 29, 2022

BUY
$269.58 - $378.88 $341,827 - $480,419
1,268 Added 5.84%
22,979 $8.71 Million
Q1 2022

Apr 29, 2022

SELL
$254.45 - $351.06 $3.65 Million - $5.03 Million
-14,338 Reduced 39.77%
21,711 $6.85 Million
Q4 2021

Feb 07, 2022

BUY
$272.01 - $353.03 $877,776 - $1.14 Million
3,227 Added 9.83%
36,049 $12.6 Million
Q3 2021

Nov 01, 2021

BUY
$295.0 - $350.58 $226,855 - $269,596
769 Added 2.4%
32,822 $9.91 Million
Q2 2021

Aug 12, 2021

BUY
$257.11 - $319.92 $471,539 - $586,733
1,834 Added 6.07%
32,053 $9.65 Million
Q1 2021

May 13, 2021

BUY
$268.3 - $380.31 $5.87 Million - $8.32 Million
21,871 Added 261.99%
30,219 $8.32 Million
Q4 2020

Feb 04, 2021

BUY
$248.13 - $308.36 $1.8 Million - $2.24 Million
7,264 Added 670.11%
8,348 $2.46 Million
Q3 2020

Nov 09, 2020

BUY
$215.51 - $272.51 $84,695 - $107,096
393 Added 56.87%
1,084 $285,000
Q2 2020

Jul 20, 2020

BUY
$127.44 - $232.72 $88,061 - $160,809
691 New
691 $156,000
Q1 2020

Apr 30, 2020

SELL
$108.83 - $165.23 $124,936 - $189,684
-1,148 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$106.59 - $164.21 $122,365 - $188,513
1,148 New
1,148 $184,000
Q3 2019

Nov 04, 2019

SELL
$113.31 - $150.51 $96,200 - $127,782
-849 Closed
0 $0
Q2 2019

Jul 29, 2019

SELL
$115.0 - $141.58 $26,220 - $32,280
-228 Reduced 21.17%
849 $120,000
Q1 2019

Apr 29, 2019

BUY
$98.85 - $134.59 $106,461 - $144,953
1,077 New
1,077 $134,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.